BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18657554)

  • 1. Flavan-3-ol derivatives are positive modulators of GABA(A) receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice.
    Fernandez SP; Mewett KN; Hanrahan JR; Chebib M; Johnston GA
    Neuropharmacology; 2008 Oct; 55(5):900-7. PubMed ID: 18657554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure.
    Fischer BD; Licata SC; Edwankar RV; Wang ZJ; Huang S; He X; Yu J; Zhou H; Johnson EM; Cook JM; Furtmüller R; Ramerstorfer J; Sieghart W; Roth BL; Majumder S; Rowlett JK
    Neuropharmacology; 2010 Dec; 59(7-8):612-8. PubMed ID: 20727364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sleep hormone oleamide modulates inhibitory ionotropic receptors in mammalian CNS in vitro.
    Coyne L; Lees G; Nicholson RA; Zheng J; Neufield KD
    Br J Pharmacol; 2002 Apr; 135(8):1977-87. PubMed ID: 11959801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sedative and anxiolytic effects of the extracts of the leaves of Stachytarpheta cayennensis in mice.
    Olayiwola G; Ukponmwan O; Olawode D
    Afr J Tradit Complement Altern Med; 2013; 10(6):568-79. PubMed ID: 24311890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPLC-based activity profiling: discovery of piperine as a positive GABA(A) receptor modulator targeting a benzodiazepine-independent binding site.
    Zaugg J; Baburin I; Strommer B; Kim HJ; Hering S; Hamburger M
    J Nat Prod; 2010 Feb; 73(2):185-91. PubMed ID: 20085307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of chlormethiazole at human recombinant GABA(A) and NMDA receptors.
    Usala M; Thompson SA; Whiting PJ; Wafford KA
    Br J Pharmacol; 2003 Nov; 140(6):1045-50. PubMed ID: 14530209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of functional receptors by the human gamma-aminobutyric acid A gamma 2 subunit.
    Martínez-Torres A; Miledi R
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3220-3. PubMed ID: 14981251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The non-benzodiazepine anxiolytic drug etifoxine causes a rapid, receptor-independent stimulation of neurosteroid biosynthesis.
    do Rego JL; Vaudry D; Vaudry H
    PLoS One; 2015; 10(3):e0120473. PubMed ID: 25785994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiolytic potential of resveratrol and rufinamide combination by modulating GABA-ergic transmission: insights from experiments, molecular docking and dynamics simulations.
    Parveen A; Alqahtani F; Javaid S; Ashraf W; Siddique F; Rawat R; Rasool MF; Ahmad T; Alasmari F; Imran I
    J Physiol Pharmacol; 2023 Oct; 74(5):. PubMed ID: 38085514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective interaction of thiopentone enantiomers with the GABA(A) receptor.
    Cordato DJ; Chebib M; Mather LE; Herkes GK; Johnston GA
    Br J Pharmacol; 1999 Sep; 128(1):77-82. PubMed ID: 10498837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of delta opioid receptors in the anxiolytic actions of benzodiazepines.
    Primeaux SD; Wilson SP; McDonald AJ; Mascagni F; Wilson MA
    Pharmacol Biochem Behav; 2006 Nov; 85(3):545-54. PubMed ID: 17109943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic-like effects of mitragynine in the open-field and elevated plus-maze tests in rats.
    Hazim AI; Ramanathan S; Parthasarathy S; Muzaimi M; Mansor SM
    J Physiol Sci; 2014 May; 64(3):161-9. PubMed ID: 24464759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evaluation of the potential anxiolytic activity of imidazo[1,5-a][1,4]diazepin agents selective for α2/3-containing GABA
    Witkin JM; Cerne R; Wakulchik M; S J; Gleason SD; Jones TM; Li G; Arnold LA; Li JX; Schkeryantz JM; Methuku KR; Cook JM; Poe MM
    Pharmacol Biochem Behav; 2017 Jun; 157():35-40. PubMed ID: 28442369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network pharmacology combined with molecular docking and experimental verification to elucidate the effect of flavan-3-ols and aromatic resin on anxiety.
    Vikhar Danish Ahmad A; Khan SW; Ali SA; Yasar Q
    Sci Rep; 2024 Apr; 14(1):9799. PubMed ID: 38684743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Search for Novel Therapies for Essential Tremor Based on Positive Modulation of α6-Containing GABA
    Handforth A; Singh RP; Treven M; Ernst M
    Tremor Other Hyperkinet Mov (N Y); 2023; 13():39. PubMed ID: 37900009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive GABA(A) receptor modulators from Acorus calamus and structural analysis of (+)-dioxosarcoguaiacol by 1D and 2D NMR and molecular modeling.
    Zaugg J; Eickmeier E; Ebrahimi SN; Baburin I; Hering S; Hamburger M
    J Nat Prod; 2011 Jun; 74(6):1437-43. PubMed ID: 21563811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABA
    Mendes FRS; da Silva AW; Ferreira MKA; Rebouças EL; Moura Barbosa I; da Rocha MN; Henrique Ferreira Ribeiro W; Menezes RRPPB; Magalhães EP; Marinho EM; Marinho MM; Bandeira PN; de Menezes JESA; Marinho ES; Dos Santos HS
    J Biomol Struct Dyn; 2023; 41(21):12426-12444. PubMed ID: 36644862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the γ-Aminobutyric Acid Type A Receptor (GABA
    Knutson DE; Kodali R; Divović B; Treven M; Stephen MR; Zahn NM; Dobričić V; Huber AT; Meirelles MA; Verma RS; Wimmer L; Witzigmann C; Arnold LA; Chiou LC; Ernst M; Mihovilovic MD; Savić MM; Sieghart W; Cook JM
    J Med Chem; 2018 Mar; 61(6):2422-2446. PubMed ID: 29481759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical data on morpholine (3,5-di-tertbutyl-4-hydroxyphenyl) methanone induced anxiolysis.
    Cabral IB; de Lima Moreira CV; Rodrigues ACC; da Silva Moreira LK; Pereira JKA; Gomides CD; Lião LM; Machado LS; Vaz BG; da Cunha LC; de Oliveira Neto JR; da Silva-Júnior EF; de Aquino TM; da Silva Santos-Júnior PF; Silva ON; da Rocha FF; Costa EA; Menegatti R; Fajemiroye JO
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):2957-2975. PubMed ID: 37097335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT
    Arias HR; Rudin D; Hines DJ; Contreras A; Gulsevin A; Manetti D; Anouar Y; De Deurwaerdere P; Meiler J; Romanelli MN; Liechti ME; Chagraoui A
    Eur J Pharmacol; 2024 Mar; 966():176329. PubMed ID: 38253116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.